Document is current
Any future updates will be listed below
-
Authors
De Witt Jansen, Bannin
Brazil, Kevin
Passmore, Peter
Buchanan, Hilary
Maxwell, Doreen
McIlfatrick, Sonja J.
Morgan, Sharon M.
Watson, Max
Parsons, Carole https://orcid.org/0000-0003-0012-3927
-
Funding
Funding for this research was provided by:
HSC Research and Development, Public Health Agency (COM/4885/13)
- License Information
-
More Information
Article History
Received: 3 October 2017
Accepted: 16 March 2018
First Online: 2 April 2018
Ethics approval and consent to participate
: Approval was obtained from the School of Pharmacy, Queen’s University Belfast, Research Ethics Committee in March 2016 (Ref: 009PMY2016). Educational governance was granted from the Northern Ireland Hospice for permission to access the Project ECHO© NI superhub, ECHO© software and use of Northern Ireland Hospice premises. All participants were provided with a written information sheet and provided written, informed consent for participation in focus group interviews and for verbatim quotations to be included in written publications and conference presentations.
: Not applicable.
: Professor Peter Passmore has received funding (educational grants) from Napp, Grünenthal and Pfizer, and has spoken and/or chaired meetings for these companies. Napp, Grünenthal and Pfizer had no role in the development, analysis or reporting of the present study. The other authors have no conflicts of interest to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
